Department of Medicine

January 5, 2026

Vanderbilt Health honored for providing care to patients with congenital heart disease

The program recognizes “the critical role of facilities providing care to patients with congenital heart disease who transition their care from pediatric cardiology to adult cardiology services.”

By Matt Batcheldor
January 5, 2026

Anna Hemnes named chair of Department of Medicine and system physician-in-chief for Vanderbilt Health

She will serve as the 11th chair of the Department of Medicine and system physician-in-chief for Vanderbilt Health. Her appointment was effective Jan. 1.

By John Howser
Members of the transplant team pose for a photo after surpassing 200 adult and pediatric heart transplants. (photo courtesy of Ashish Shah)
December 23, 2025

Vanderbilt Health performs record number of adult and pediatric heart transplants during 2025

As in prior years, the success of Vanderbilt Health’s transplant program is a testament to the greatness of individuals and innovations alike and to the tremendous power of teamwork.

By Matt Batcheldor
Annet Kirabo, DVM, MSc, PhD
December 23, 2025

Annet Kirabo named “Top Scholar” in hypertension

By Bill Snyder
December 12, 2025

Lucy Spalluto and Jennifer Lewis awarded $1 million lung cancer screening grant

Lung cancer is the leading cause of cancer death in the United States, with incidence higher in veterans compared to the civilian population.

By Derek Scancarelli
December 10, 2025

Sedative choice could improve outcomes for breathing tube patients

It’s the first study to demonstrate cardiovascular risks of high doses of ketamine (low blood pressure, arrhythmia), side effects that have not been well studied in the past.

By Craig Boerner
December 8, 2025

Interim data reported for multiple myeloma off-the-shelf CAR-T therapy  

Vanderbilt-Ingram Cancer Center accrued the most patients nationwide for the clinical trial for P-BCMA-ALLO1 – a chimeric antigen receptor T cell therapy (CAR-T) derived from healthy donors’ white blood cells.
By Tom Wilemon
December 4, 2025

Vanderbilt-Ingram researchers present cancer advancements at ASH 2025 

Established in 1958, ASH is the world’s largest professional organization for clinicians and scientists who study blood diseases. 
By Tom Wilemon
December 3, 2025

Large-scale integration of genomics, proteomics and clinical records identifies cancer risk proteins and potential therapeutics

A new study identifies previously unreported protein biomarkers and candidate drug targets across six major cancer types and highlights approved drugs with potential cancer preventive effects.
By Leigh MacMillan
December 2, 2025

Ketamine fails surgical recovery trial

In a large, placebo-controlled, randomized trial, the pain reliever ketamine posed side effects while failing to aid patient recovery after major surgery.
By Paul Govern
December 1, 2025

Timothy Sterling receives $5.7 million to study tuberculosis transmission

Using molecular and other data from both the bacterial and human sides of the equation, a multi-institutional team will develop prediction models of TB transmission.
By Paul Govern
November 26, 2025

Protein plays dual roles in repairing damaged kidney

These findings were unexpected and demonstrate that the actin cytoskeleton repairs cell organelles like mitochondria in a regulated way.
By Bill Snyder
November 14, 2025

Andrew DeFilippis named director of VUMC’s Division of Cardiovascular Medicine

He serves as associate chief of staff at Vanderbilt University Hospital and served as the medical director of the Cardiovascular Intensive Care Unit from 2020 to 2025.
By Matt Batcheldor
1 2 3 4 … 125